Latest Daiichi Sankyo Stories
DUBLIN, March 5, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/w2749d/antibody_drug) has announced the addition of the "Antibody
Pharmacist Partners is pleased to announce its participation in PanAgora Pharma's upcoming Customer Experience Summit March 5-6, 2014 in Princeton, NJ. NEW YORK, Feb.
MUMBAI, India, February 11, 2014 /PRNewswire/ -- Bharat Book Bureau presents Global Pharmaceutical & Biotechnology Outlook 2014: Japan Pharma.
Global Pharmaceutical & Biotechnology Outlook 2014: Major US and EU report provide analysis of individual large cap companies, promising drug candidates in their late stage pipelines, competitive
DUBLIN, February 5, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/vgwhc9/new_oral) has announced the addition of the "Concise Analysis
DUBLIN, January 29, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/ztm9m5/antibodydrug) has announced the addition of the "Antibody-Drug
PLANTATION, Fla., Jan. 28, 2014 /PRNewswire/ -- Neurotrope, Inc. (OTCQB: NTRP) (the "Company") announced today that it has hired Dr.
Submission based on the two largest comparative phase 3 clinical trials of a novel oral anticoagulant in patients with non-valvular atrial fibrillation or symptomatic venous thromboembolism TOKYO
- The parings of haberdine; also, any kind of fragments.